NTRK fusions and Trk proteins: what are they and how to test for them
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NTRK fusions and Trk proteins: what are they and how to test for them
Authors
Keywords
Pan-TRK, Immunohistochemistry, Break apart FISH, RNA next generation sequencing, Secretory carcinoma
Journal
HUMAN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-30
DOI
10.1016/j.humpath.2021.03.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
- (2020) Yoichi Naito et al. International Journal of Clinical Oncology
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
- (2020) David S Hong et al. LANCET ONCOLOGY
- Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)
- (2020) Ying-Hsia Chu et al. MODERN PATHOLOGY
- Congenital mesoblastic nephroma is characterized by kinase mutations including EGFR internal tandem duplications, ETV6‐NTRK3 fusion, and rare KLHL7‐BRAF fusion
- (2020) Manli Zhao et al. HISTOPATHOLOGY
- NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm
- (2020) Daniel D. Wong et al. PATHOLOGY
- Molecular and clinicopathologic features of gliomas harboring NTRK fusions
- (2020) Matthew Torre et al. Acta Neuropathologica Communications
- Testing algorithm for identification of patients with TRK fusion cancer
- (2019) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL PATHOLOGY
- Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from TRK Inhibitor Therapy
- (2019) Susan J. Hsiao et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
- (2019) C Marchiò et al. ANNALS OF ONCOLOGY
- Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic Platforms
- (2019) James P. Solomon et al. CANCER RESEARCH
- Revisiting NTRKs as an emerging oncogene in hematological malignancies
- (2019) Sunil K. Joshi et al. LEUKEMIA
- NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
- (2019) James P. Solomon et al. MODERN PATHOLOGY
- TRK inhibitors in TRK fusion-positive cancers
- (2019) A Drilon ANNALS OF ONCOLOGY
- Identifying patients with NTRK fusion cancer
- (2019) J P Solomon et al. ANNALS OF ONCOLOGY
- Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
- (2019) A Amatu et al. ANNALS OF ONCOLOGY
- Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assays
- (2019) Nicole Pfarr et al. GENES CHROMOSOMES & CANCER
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors
- (2018) Erin R. Rudzinski et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma
- (2018) Sarah Chiang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- (2018) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular characterization of cancers with NTRK gene fusions
- (2018) Zoran Gatalica et al. MODERN PATHOLOGY
- Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samples
- (2018) Hannah L. Williams et al. VIRCHOWS ARCHIV
- TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening
- (2018) Catherine M. Albert et al. JOURNAL OF CLINICAL ONCOLOGY
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy
- (2017) Alanna J Church et al. MODERN PATHOLOGY
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
- (2017) Christophe Massard et al. Cancer Discovery
- BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations
- (2017) Safoora Deihimi et al. Oncotarget
- ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors
- (2016) Ali H. Alassiri et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors
- (2016) Eileen Shi et al. Journal of Translational Medicine
- Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
- (2016) E. Ardini et al. MOLECULAR CANCER THERAPEUTICS
- Testing for ROS1 in non-small cell lung cancer: a review with recommendations
- (2016) Lukas Bubendorf et al. VIRCHOWS ARCHIV
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
- (2014) Thomas Wiesner et al. Nature Communications
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer
- (2013) Rebecca J. Leeman-Neill et al. CANCER
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression
- (2011) Pooja Vasudev et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity
- (2010) Alena Skálová et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation